RayzeBio inc (DELISTED) (RYZB:DL)
62.49
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
RayzeBio Cash from Investing (Quarterly): -146.77M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -146.77M |
Date | Value |
---|---|
September 30, 2022 | 48.07M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-146.77M
Minimum
Sep 2023
48.07M
Maximum
Sep 2022
-49.35M
Average
-49.35M
Median
Cash from Investing (Quarterly) Benchmarks
Bristol-Myers Squibb Co | -19.62B |
Karuna Therapeutics Inc (DELISTED) | 92.44M |
Ambrx Biopharma Inc (DELISTED) | 6.164M |
Pfizer Inc | 1.732B |
Mirati Therapeutics Inc (DELISTED) | -62.19M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -45.26M |
Cash from Financing (Quarterly) | 314.84M |
Free Cash Flow Per Share (Quarterly) | -5.005 |